Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole versus betamethasone valerate skin biomarker validation study in adult atopic dermatitis
2019-002643-23Phase 2Unknown
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jan 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in atopic dermatitis (AD) comparing Crisaborole arm with Betamethasone valerate arm (2 arms). Primary endpoint: Change in epidermal thickness between treatment sites. Status: unknown.
02
Drugs
crisaborolebetamethasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2019-002643-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002643-23.